Cited by 514-3-3 protein interactionsAnimal Virus Infections StudiesViral Infections and Immunology Research

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Encephalomyocarditis virus protein 2B* interacts with 14-3-3 proteins through a phosphorylated C-terminal binding motif

Open access

Published version of a preprint

Abstract

Encephalomyocarditis virus (EMCV) has been an important model RNA virus for decades. Although most of the EMCV proteins are obtained via proteolytic cleavage of a long polyprotein, 2B* is expressed from a short overlapping open reading frame via an unusual protein-stimulated temporally dependent ribosomal frameshifting mechanism. Mutant viruses that are unable to express 2B* have a small plaque phenotype due to delayed onset and inefficient progression of multiple lytic cell death pathways. However, the mechanism by which 2B* promotes these pathways has not yet been characterized. By tagging 2B* within the viral genome, we identified putative interaction partners of 2B* and showed that 2B* binds all seven members of the 14-3-3 protein family during virus infection. Binding is entirely dependent on a mode III motif containing a phosphoserine (RRNpSS) at the 2B* C terminus. This may impede other functions of the 14-3-3 proteins, including their role in promoting antiviral signaling. Ablating the 2B*:14-3-3 interaction had no effect upon plaque size, indicating that the function of this interaction is unrelated to the role of 2B* in promoting lytic cell death. This work expands our knowledge of the protein complement of this important model virus and the binding repertoire and specificity of host 14-3-3 proteins. IMPORTANCE: Encephalomyocarditis virus (EMCV) infects a range of species, causing economically important reproductive disorders in pigs and encephalitis and myocarditis in rodents. Due to its wide host range, it is an important model pathogen for investigating virus-host interactions. EMCV expresses an accessory protein, 2B*, from an overlapping open reading frame via an unusual ribosomal frameshifting mechanism. Although the frameshifting mechanism has been established, the function of the 2B* protein had not been explored until recently. Here, we determined the host proteins to which 2B* binds and found that it specifically binds to all members of the 14-3-3 protein family, which, among other roles, contribute to the innate immune response to viral infection in mammalian cells. The interaction requires a specific stretch of amino acids at the end of 2B*. Binding to 2B* may reduce the opportunities for these 14-3-3 proteins to bind to host proteins and perform their usual roles; therefore, by interacting with the 14-3-3 proteins, 2B* may affect multiple host cell functions, including immune response activation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/mbio.01008-25

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 80

  1. 10.1099/vir.0.047571-0 · DOI
  2. 10.1073/pnas.1102932108 · DOI
  3. 10.1038/ncomms15582 · DOI
  4. 10.1038/s41467-021-27400-7 · DOI
  5. 10.1128/JVI.01043-15 · DOI
  6. 10.1093/nar/gkab969 · DOI
  7. 10.1099/jgv.0.002075 · DOI
  8. 10.1128/JVI.00231-21 · DOI
  9. 10.1016/j.chom.2019.09.012 · DOI
  10. 10.1371/journal.ppat.1008146 · DOI
  11. 10.1128/jvi.00604-23 · DOI
  12. 10.1099/jgv.0.000888 · DOI
  13. 10.1261/rna.061051.117 · DOI
  14. 10.1371/journal.ppat.1005185 · DOI
  15. 10.1128/JVI.79.17.11062-11070.2005 · DOI
  16. 10.1038/s41388-018-0348-3 · DOI
  17. 10.1158/0008-5472.CAN-06-3431 · DOI
  18. 10.1016/j.semcancer.2006.03.002 · DOI
  19. 10.3389/fendo.2019.00797 · DOI
  20. 10.1105/tpc.131110 · DOI
  21. 10.1371/journal.ppat.1007582 · DOI
  22. 10.1016/j.chom.2012.04.006 · DOI
  23. Jia H, Liang Z, Zhang X, Wang J, Xu W, Qian H. 2017. 14-3-3 proteins: an important regulator of autophagy in diseases. Am J Transl Res 9:4738–4746.
  24. 10.1038/leu.2017.288 · DOI
  25. 10.1093/nar/gkab975 · DOI
  26. 10.1042/BJ20091834 · DOI
  27. 10.1073/pnas.0406871102 · DOI
  28. 10.1016/j.febslet.2006.02.014 · DOI
  29. 10.1016/s0092-8674(00)81067-3 · DOI
  30. 10.1073/pnas.0605779103 · DOI
  31. 10.1111/febs.15215 · DOI
  32. 10.1111/febs.15574 · DOI
  33. 10.1038/embor.2009.150 · DOI
  34. 10.1073/pnas.1516631113 · DOI
  35. 10.1016/j.jmb.2012.08.009 · DOI
  36. 10.1016/s1097-2765(00)80363-9 · DOI
  37. 10.1016/s0092-8674(00)80487-0 · DOI
  38. 10.1038/nature05732 · DOI
  39. 10.1016/s1074-7613(00)00053-4 · DOI
  40. 10.1038/nri1604 · DOI
  41. 10.1159/000226248 · DOI
  42. 10.1016/bs.apcsb.2021.12.004 · DOI
  43. 10.1039/c1mb05216k · DOI
  44. 10.1016/j.jbc.2023.104855 · DOI
  45. 10.1038/s42003-021-02518-y · DOI
  46. 10.1016/j.str.2016.12.005 · DOI
  47. 10.1016/j.molcel.2006.12.017 · DOI · Paper page
  48. 10.1042/BCJ20161078 · DOI
  49. 10.1016/s0014-5793(01)03288-4 · DOI
  50. 10.1128/MCB.00838-14 · DOI
  51. 10.1016/j.jbc.2022.102513 · DOI
  52. 10.1093/emboj/19.11.2652 · DOI
  53. 10.1038/sj.emboj.7601530 · DOI
  54. 10.1021/bi982492m · DOI
  55. 10.1021/bi991353h · DOI
  56. 10.1074/jbc.273.26.16305 · DOI
  57. 10.1016/s0960-9822(03)00208-2 · DOI
  58. 10.4161/15592324.2014.977721 · DOI
  59. 10.1074/jbc.M306707200 · DOI
  60. 10.1073/pnas.1722437115 · DOI
  61. 10.1073/pnas.2119531119 · DOI
  62. 10.1083/jcb.200112059 · DOI
  63. 10.1128/JVI.43.1.250-261.1982 · DOI
  64. 10.1016/j.virol.2020.01.001 · DOI
  65. 10.1016/j.virol.2017.12.017 · DOI
  66. 10.3390/genes12060809 · DOI
  67. 10.1016/j.celrep.2023.112179 · DOI
  68. 10.1016/j.imlet.2004.09.013 · DOI
  69. 10.4049/jimmunol.181.9.6384 · DOI
  70. 10.1038/343474a0 · DOI · Paper page
  71. 10.1111/cmi.12425 · DOI
  72. 10.1038/nmeth.2019 · DOI · Paper page
  73. 10.1186/s12859-017-1934-z · DOI
  74. 10.1038/s41596-018-0082-x · DOI
  75. 10.1038/nprot.2016.136 · DOI
  76. 10.1093/nar/gkab1038 · DOI · Paper page
  77. 10.1038/nmeth.3901 · DOI · Paper page
  78. 10.1038/nmeth.3213 · DOI · Paper page
  79. 10.1093/nar/gkac439 · DOI
  80. 10.1038/s41467-023-38869-9 · DOI

Metadata

Authors
Nguyen, S. K., Anders, N., Holmes, S., Barrow, H. G., Lukhovitskaya, N., Jahun, A. S., Georgana, I., Caller, L. G., Edgar, J. R., Graham, S. C., Emmott, E., Firth, A. E., & Stewart, H.
Affiliations
  • University of Cambridge (GB)
  • University of Liverpool (GB)
Corresponding author
Stewart, Hazel
Venue
mBio
Published
2025-09-10
Volume
16
Issue
9
Pages
e0100825-e0100825
ISSN
2150-7511 (ISSN-L)
OpenAlex
W4413283916
Cited by
5
References
2
Citations by year
2026: 3 · 2025: 2
FWCI
1.49
Type
journal article
Language
en
Open access
Locations
  • mBio (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • HAL (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
  • Apollo (cc-by)
Funders
  • Wellcome Trust (106207/Z/14/Z,220814/Z/20/Z, 227831/Z/23/Z, 216370/Z/19/Z)
  • European Research Council (646891)
  • Academy of Medical Sciences (SBF006\1008)
  • Medical Research Council (MR/X000885/1)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › 14-3-3 protein interactions
  • Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
  • Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
Keywords
encephalomyocarditis virus, 14-3-3 proteins, protein-protein interaction, ribosomal frameshifting, lytic cell death, host-virus interaction, antiviral innate immunity, viral accessory proteins, RNA viruses, plaque size
MeSH terms
Animals, Encephalomyocarditis virus, Cricetinae, Phosphorylation, Phosphoserine, Viral Proteins, Genome, Viral, Cardiovirus Infections, Amino Acid Motifs, 14-3-3 Proteins, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review